Training protocol
Zone 2 aerobic training
Graded on: VO2max The most oxygen the body can use during all-out exercise, a standard measure of aerobic fitness. (cardiorespiratory fitness), an objective functional measure.
Compare this record with another, side by side →
How this letter has changedLatest: October 2026 · Upgraded.
Same evidence as the Zone 2 protocol: Gormley et al. (Med Sci Sports Exerc, 2008; PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 18580415) replicated The same finding reproduced by a separate research group. A result seen once can be chance or bias; a replicated one is harder to explain away. by the DREW trial (Church et al., JAMA, 2007; PMID 17507344) and pooled in Nuuttila et al. (Scand J Med Sci Sports, 2026; PMID 41543030). Replicated instrument-measured VO2max is A. The record keeps its statement that higher intensities produce larger gains. Applied the written grade definition under the editor's standing instruction of October 2026 (Arnold Sandlow, D.C.).PMID 17507344 PMID 18580415 PMID 41543030
Every change to a letter on this site is dated and published. The full evidence log →
Zone 2 training is steady aerobic exercise at a moderate pace, easy enough to keep going and breathe through the nose. In trials, moderate training raised how much oxygen the body can use during hard effort, a lab-measured sign of fitness. One trial of 464 inactive women over six months found gains that grew with more exercise. Harder training raised fitness even more, so Zone 2 is not the most effective pace. No trial has measured deaths or heart events. Heart drugs called beta-blockers lower heart rate, so heart-rate zones can be wrong for people taking them.
A letter describes the human evidence, not the product, the manufacturer, or the intervention's worth.
See the full evidence record →Graded on VO2max (cardiorespiratory fitness), an objective functional measure.
Why this gradeThe reasoning, and what the grade does not cover.
Grade A by the instrument-measured function route: measured VO2max is a qualifying endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. under the written rule, and the gain from Zone 2 training is replicated by independent groups. Gormley et al. (Med Sci Sports Exerc, 2008; PMID 18580415): the moderate-intensity arm raised VO2max 10.0 percent against control in 61 adults over 6 weeks, less than the vigorous and near-maximal arms (14.3 and 20.6 percent). Church et al. (JAMA, 2007; PMID 17507344), the DREW trial: 464 sedentary women at 50 percent of peak VO2 for 6 months, peak oxygen consumption 4.2 to 8.2 percent higher than control in dose order. Nuuttila et al. (Scand J Med Sci Sports, 2026; PMID 41543030) pool 50 randomized trials below the first threshold. Moved from B in October 2026 by the written rule.
WHAT THIS GRADE DOES NOT COVERmortality or any clinical event, which no trial measured; the claim that Zone 2 is the most effective intensity, which the dose-response trials contradict; and any wearable's zone estimate, which is not what the trials measured.
Shared endpoint: Measured VO2max after continuous aerobic training at or near Zone 2 intensity against a non-exercising control
- Old Dominion University, Norfolk, Virginia, USA (Gormley, Swain): VO2max rose 10.0 percent in the moderate-intensity arm (50 percent of VO2 reserve, 60 minutes four days a week) against a non-exercising control, 61 healthy adults, 6 weeks. PMID 18580415 · Funding: academic; no funding statement in the indexed record
- Pennington Biomedical Research Center, Baton Rouge, and the Cooper Institute, Dallas, USA (Church, Blair): Peak oxygen consumption rose 4.2, 6.0 and 8.2 percent against a non-exercise control at 72, 136 and 192 minutes a week at 50 percent of peak VO2, 464 sedentary postmenopausal women, 6 months. PMID 17507344 · Funding: National Heart, Lung, and Blood Institute (NIH)
What the replication does not cover: Both trials trained at about 50 percent of VO2 reserve or peak VO2, which is the low end of Zone 2; neither used a lactate or ventilatory threshold to set intensity. The DREW trial's middle dose, 136 minutes a week, is the closest match to 150 minutes a week; Gormley trained for 240 minutes a week. Nuuttila 2026 (PMID 41543030) pools 50 randomized trials below the first threshold and agrees. None of the trials reports a clinical event.
A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →
Zone 2 intensity is appropriate for most adults including those with managed cardiovascular conditions. People with uncontrolled hypertension, known arrhythmias, or recent cardiac events should obtain medical clearance before starting any aerobic training program.
The evidence, in fullThree papers, each linked to its PubMed record.
Gormley et al. (Med Sci Sports Exerc, 2008; PMID 18580415): 61 healthy adults randomized to moderate (50 percent of VO2 reserve), vigorous or near-maximal cycling or a non-exercising control for 6 weeks; VO2max rose 10.0, 14.3 and 20.6 percent. Church et al. (JAMA, 2007; PMID 17507344), the DREW trial: 464 sedentary postmenopausal women randomized to a non-exercise control or three doses of physical activity at 50 percent of peak VO2 for 6 months; cardiorespiratory fitness (peak oxygen consumption) rose 4.2, 6.0 and 8.2 percent against control. Nuuttila et al. (Scand J Med Sci Sports, 2026; PMID 41543030): meta-analysis A study that pools the numbers from several trials into one combined estimate. of 50 randomized trials of low-intensity endurance training below the first threshold; large effect on VO2max, with higher intensity giving larger gains. Grade A: replicated instrument-measured VO2max.
VO2max via field test at baseline and every 12 weeks. Zone 2 training is occurring by verifying sustainable nasal breathing throughout sessions: this approximates the lactate threshold boundary. Resting heart rate monthly as an adaptation indicator; a reduction of 5+ beats per minute over 12 weeks confirms meaningful aerobic adaptation.
Evidence notes: randomized trial, meta-analysis
Endpoint graded: VO2max (cardiorespiratory fitness), an objective functional measure (functional)
Last reviewed: July 2026
Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.
As studiedDose, form, population and duration for every use.
A grade describes the intervention that was tested. Where the product on the shelf differs from it, this says so.
Primary evidenceThree papers, each linked to its PubMed record.
Gormley et al. (Med Sci Sports Exerc, 2008; PMID 18580415): 61 healthy adults randomized to moderate (50 percent of VO2 reserve), vigorous or near-maximal cycling or a non-exercising control for 6 weeks; VO2max rose 10.0, 14.3 and 20.6 percent. Church et al. (JAMA, 2007; PMID 17507344), the DREW trial: 464 sedentary postmenopausal women randomized to a non-exercise control or three doses of physical activity at 50 percent of peak VO2 for 6 months; cardiorespiratory fitness (peak oxygen consumption) rose 4.2, 6.0 and 8.2 percent against control. Nuuttila et al. (Scand J Med Sci Sports, 2026; PMID 41543030): meta-analysis of 50 randomized trials of low-intensity endurance training below the first threshold; large effect on VO2max, with higher intensity giving larger gains. Grade A: replicated instrument-measured VO2max.
This page carries a letter. EBL takes no commission, referral fee or payment of any kind on anything it grades. No letter has been bought and none is for sale. Products listed under this modality may be commercial partners, and their purchase links may earn EBL a commission. Those products carry no letter of their own, every relationship is disclosed beside the link, and where a product does not deliver what the trials tested, this page says so regardless of who pays.
How this is enforced
That is not a promise, it is a build condition. Two checks run on every deploy: one refuses to publish if a commission is claimed on anything graded, the other refuses if a page names a commercial relationship that is not declared in the register. If either fails, this page does not go live. You can read how the checks work, and what they do not cover, on the evidence integrity page.
Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy
© Evidence Based Longevity, Inc.. All rights reserved
These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.
How EBL searched for the trials (1 search)
The search that was run, what it returned, and what was left out and why, so the absence of evidence can be checked as well as its presence.
(VO2max[ti] OR "maximal oxygen uptake"[ti] OR "cardiorespiratory fitness"[ti]) AND (training[ti] OR exercise[ti]) AND randomized controlled trial[pt] AND (control[tiab] OR intensity[tiab]) AND (sedentary[tiab] OR untrained[tiab] OR healthy[tiab])Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →